Synta Pharmaceuticals Corp. (MDGL)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
23-Nov-18 8:53 PM
View: 
Friedman Paul A
Chief Executive Officer
Director
Synta Pharmaceuticals Corp. (MDGL) 20-Nov-18Market Purchase 4,000$117.88$471,520.003%
157.13K to 161.13K
15%
19-Nov-18 6:09 PM
View: 
Craves Fred B
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 19-Nov-18Market Purchase 2,000$124.69$249,387.00< 1%
296.07K to 298.07K
8%
19-Nov-18 6:26 PM
View: 
Friedman Paul A
Chief Executive Officer
Director
Synta Pharmaceuticals Corp. (MDGL) 19-Nov-18Market Purchase 4,000$124.00$496,000.003%
153.13K to 157.13K
9%
14-Nov-18 6:43 PM
View: 
Milligan David V
Director
Synta Pharmaceuticals Corp. (MDGL) 14-Nov-18Option Exercise 10,000$16.46$164,600.0050%
20.0K to 30.0K
19-Sep-18 4:25 PM
View: 
Milligan David V
Director
Synta Pharmaceuticals Corp. (MDGL) 18-Sep-18Option Exercise 20,000$9.45$189,000.00100%
0 to 20.0K
12-Jun-18 9:02 PM
View: 
Craves Fred B
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale 274,092$287.46$78,790,496.00(5%)
5.65M to 5.38M
53%
13-Jun-18 3:53 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Option Sale 7,957$287.46$2,287,320.00(15%)
51.77K to 43.81K
53%
12-Jun-18 8:56 PM
View: 
Friedman Paul A
Chief Executive Officer
Director
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale
Duplicate
73,526$287.46$21,135,800.00(10%)
729.07K to 655.54K
53%
12-Jun-18 8:50 PM
View: 
Bay City Capital LLC
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale 280,000$287.46$80,488,800.00(5%)
5.66M to 5.38M
53%
13-Jun-18 3:53 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale 2,142$287.46$615,739.00(5%)
43.81K to 41.67K
53%
12-Jun-18 8:55 PM
View: 
Taub Rebecca
Chief Medical Officer, EVP R&D
Director
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale 73,526$287.46$21,135,800.0013%
582.01K to 655.54K
(53%)
12-Jun-18 9:02 PM
View: 
Craves Fred B
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Market Sale 5,908$287.46$1,698,310.00< 1%
5.65M to 5.65M
(53%)
13-Jun-18 3:53 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 11-Jun-18Option Exercise 7,957$86.64$689,409.0018%
43.81K to 51.77K
24-Aug-17 4:04 PM
View: 
Levy Richard S
Director
Synta Pharmaceuticals Corp. (MDGL) 23-Aug-17Market Purchase 2,000$16.12$32,235.9028%
7.1K to 9.1K
739%
23-Aug-17 4:03 PM
View: 
Levy Richard S
Director
Synta Pharmaceuticals Corp. (MDGL) 22-Aug-17Market Purchase 3,550$16.12$57,209.10100%
3.55K to 7.1K
740%
22-Aug-17 4:05 PM
View: 
Levy Richard S
Director
Synta Pharmaceuticals Corp. (MDGL) 21-Aug-17Market Purchase 3,550$15.88$56,358.30100%
0 to 3.55K
752%
22-Jul-16 5:18 PM
View: 
Rieder Wendy E
Former SVP, Gen. Counsel
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 25,714----4543%
0.57K to 26.28K
22-Jul-16 5:23 PM
View: 
Schor Chen
Former President and CEO
Director
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Payment of Exercise 14,250$9.48$135,090.00(28%)
51.43K to 37.18K
26-Jul-16 5:26 PM
View: 
Friedman Paul A
Chief Executive Officer
Director
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 143,703----100%
0 to 143.7K
26-Jul-16 5:55 PM
View: 
Craves Fred B
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 5,657,850----1911%
296.07K to 5.95M
26-Jul-16 5:26 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 22,969----119%
19.31K to 42.28K
22-Jul-16 5:18 PM
View: 
Rieder Wendy E
Former SVP, Gen. Counsel
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Payment of Exercise 8,550$9.48$81,054.00(33%)
26.28K to 17.73K
26-Jul-16 5:25 PM
View: 
Taub Rebecca
Chief Medical Officer, EVP R&D
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 729,066----100%
0 to 729.07K
26-Jul-16 5:26 PM
View: 
Friedman Paul A
Chief Executive Officer
Director
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant
Duplicate
729,066----507%
143.7K to 872.77K
22-Jul-16 5:22 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Payment of Exercise 8,548$9.48$81,035.00(31%)
27.86K to 19.31K
22-Jul-16 5:23 PM
View: 
Schor Chen
Former President and CEO
Director
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 42,857----500%
8.57K to 51.43K
26-Jul-16 5:25 PM
View: 
Taub Rebecca
Chief Medical Officer, EVP R&D
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 432,872----59%
729.07K to 1.16M
26-Jul-16 5:55 PM
View: 
Craves Fred B
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 296,067----100%
0 to 296.07K
22-Jul-16 5:22 PM
View: 
Schneebaum Marc R
Chief Financial Officer
Synta Pharmaceuticals Corp. (MDGL) 22-Jul-16Grant 25,714----1200%
2.14K to 27.86K
05-Jan-16 6:32 PM
View: 
Morenstein Scott D
Director
Synta Pharmaceuticals Corp. (MDGL) 01-Jan-16Grant 17,857----100%
0 to 17.86K
15-Dec-15 4:34 PM
View: 
Gollust Keith R
Director
Synta Pharmaceuticals Corp. (MDGL) 14-Dec-15Market Sale 300,000$0.32$96,690.00(12%)
2.42M to 2.12M
(1087%)
15-Dec-15 4:34 PM
View: 
Gollust Keith R
Director
Synta Pharmaceuticals Corp. (MDGL) 11-Dec-15Market Sale 300,000$0.37$111,030.00(11%)
2.72M to 2.42M
(934%)
09-Dec-15 5:00 PM
View: 
Gollust Keith R
Director
Synta Pharmaceuticals Corp. (MDGL) 09-Dec-15Market Sale 145,892$0.38$55,234.70(5%)
2.86M to 2.72M
(911%)
09-Dec-15 5:00 PM
View: 
Gollust Keith R
Director
Synta Pharmaceuticals Corp. (MDGL) 08-Dec-15Market Sale 300,000$0.38$114,060.00(9%)
3.16M to 2.86M
(906%)
08-Dec-15 2:09 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 08-Dec-15Market Sale 1,369,640$0.37$506,766.00(6%)
23.08M to 21.71M
(934%)
08-Dec-15 2:09 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 07-Dec-15Market Sale 100$0.41$41.00(< 1%)
23.08M to 23.08M
(833%)
09-Dec-15 5:00 PM
View: 
Gollust Keith R
Director
Synta Pharmaceuticals Corp. (MDGL) 07-Dec-15Market Sale 300,000$0.39$115,830.00(9%)
3.46M to 3.16M
(891%)
08-Dec-15 2:09 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 04-Dec-15Market Sale 153,607$0.41$63,347.50(< 1%)
23.24M to 23.08M
(828%)
03-Dec-15 5:49 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 03-Dec-15Market Sale 262,434$0.41$108,621.00(1%)
23.5M to 23.24M
(825%)
03-Dec-15 5:49 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 02-Dec-15Market Sale 687,603$0.43$293,744.00(3%)
24.19M to 23.5M
(796%)
03-Dec-15 5:49 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 01-Dec-15Market Sale 480,716$0.43$206,804.00(2%)
24.67M to 24.19M
(789%)
30-Nov-15 5:23 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 30-Nov-15Market Sale 640,505$0.43$277,659.00(3%)
25.31M to 24.67M
(783%)
30-Nov-15 5:23 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 27-Nov-15Market Sale 934,595$0.50$462,625.00(4%)
26.24M to 25.31M
(673%)
30-Nov-15 5:23 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 25-Nov-15Market Sale 1,503,720$0.49$733,966.00(5%)
27.75M to 26.24M
(684%)
24-Nov-15 5:27 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 24-Nov-15Market Sale 538,129$0.44$237,476.00(2%)
28.28M to 27.75M
(767%)
24-Nov-15 5:27 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 23-Nov-15Market Sale 635,453$0.44$277,629.00(2%)
28.92M to 28.28M
(776%)
20-Nov-15 5:42 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 20-Nov-15Market Sale 230,283$0.44$102,038.00(< 1%)
29.15M to 28.92M
(764%)
20-Nov-15 5:42 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 19-Nov-15Market Sale 1,174,650$0.50$585,331.00(4%)
30.32M to 29.15M
(668%)
20-Nov-15 5:42 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 18-Nov-15Market Sale 108,154$0.43$46,819.90(< 1%)
30.43M to 30.32M
(784%)
17-Nov-15 5:08 PM
View: 
Kovner Bruce
Director
10% Owner
Synta Pharmaceuticals Corp. (MDGL) 17-Nov-15Market Sale 700,618$0.42$295,661.00(2%)
31.13M to 30.43M
(807%)